Multicenter exploration of tenecteplase transition factors: A quantitative analysis

Sidarrth Prasad, Erica M. Jones, Mehari Gebreyohanns, Yoon Kwon, Dai Wai M. Olson, Jane A. Anderson, Sean I. Savitz, Salvador Cruz-Flores, Steven J. Warach, Charlotte E. Rhodes, Mark P. Goldberg, Nneka L. Ifejika

Producción científica: Articlerevisión exhaustiva

1 Cita (Scopus)

Resumen

Background: Tenecteplase (TNK) is gaining recognition as a novel therapy for acute ischemic stroke (AIS). Despite TNK offering a longer half-life, time and cost saving benefits and comparable treatment and safety profiles to Alteplase (ALT), the adoption of TNK as a treatment for AIS presents challenges for hospital systems. Objective: Identify barriers and facilitators of TNK implementation at acute care hospitals in Texas. Methods: This prospective survey used open-ended questions and Likert statements generated from content experts and informed by qualitative research. Stroke clinicians and nurses working at 40 different hospitals in Texas were surveyed using a virtual platform. Results: The 40 hospitals had a median of 34 (IQR 24.5–49) emergency department beds and 42.5 (IQR 23.5–64.5) inpatient stroke beds with 506.5 (IQR 350–797.5) annual stroke admissions. Fifty percent of the hospitals were Comprehensive Stroke Centers, and 18 (45 %) were solely using ALT for treatment of eligible AIS patients. Primary facilitators to TNK transition were team buy-in and a willingness of stroke physicians, nurses, and pharmacists to adopt TNK. Leading barriers were lack of clinical evidence supporting TNK safety profile inadequate evidence supporting TNK use and a lack of American Heart Association guidelines support for TNK administration in all AIS cases. Conclusion: Understanding common barriers and facilitators to TNK adoption can assist acute care hospitals deciding to implement TNK as a treatment for AIS. These findings will be used to design a TNK adoption Toolkit, utilizing implementation science techniques, to address identified obstacles and to leverage facilitators.

Idioma originalEnglish (US)
Número de artículo107592
PublicaciónJournal of Stroke and Cerebrovascular Diseases
Volumen33
N.º4
DOI
EstadoPublished - abr 2024

ASJC Scopus subject areas

  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine
  • Rehabilitation
  • Surgery

Huella

Profundice en los temas de investigación de 'Multicenter exploration of tenecteplase transition factors: A quantitative analysis'. En conjunto forman una huella única.

Citar esto